Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Perrone

Showing results (51-60 of 272) with videos related to

Pageof 28
Sort By:
The Oncologist|August 2, 2006
Tyrosine kinase inhibitors of vascular endothelial growth factor receptors in clinical trials: current status and future directionsAlessandro Morabito, Ermelinda De Maio, Massimo Di Maio, et al.
Clinical Lung Cancer|July 25, 2008
An international, multicenter, randomized phase III study of first-line erlotinib followed by second-line cisplatin/gemcitabine versus first-line cisplatin/gemcitabine followed by second-line erlotinib in advanced non-small-cell lung cancer: treatment rationale and protocol dynamics of the TORCH trialCesare Gridelli, Charles Butts, Fortunato Ciardiello, et al.
Journal of Clinical Gastroenterology|October 24, 2002
Hepatocellular carcinoma: systemic treatmentsMassimo Di Maio, Ermelinda De Maio, Francesco Perrone, et al.
JAMA Network Open|December 2, 2022
Number Needed to Treat in Trials of Targeted Therapies for Advanced Ovarian CancerMichele Bartoletti, Sandro Pignata, Domenica Lorusso, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 19, 2009
Trastuzumab beyond progression: is the risk of cardiac toxicity really not increased?Alessandro Morabito, Maria Carmela Piccirillo, Ermelinda De Maio, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|February 28, 2012
The use of a chimaeric sero-muscular flap to prevent anastomotic leakage in head and neck reconstruction with free ileocolon flapFrancesco Perrone, Bahar Bassiri Gharb, Antonio Rampazzo, et al.
Tumori|April 20, 2026
Ethics in the evaluation of the quality of scientific research: An AIOM-TJ roundtableAlessio Vittorio Adani, Paolo Crosetto, Laura Galbiati, et al.
Journal of Cancer Policy|August 26, 2023
Cross-cultural adaptation of the PROFFIT Instrument to measure financial toxicity in people living with cancer within a UK populationAlkesh Patel, Francesco Perrone, Darren M Ashcroft, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2013
Reply to V. Lorusso et alCesare Gridelli, Ciro Gallo, Charles A Butts, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|November 1, 2012
Three uses of an extra length of jejunum in pharyngo-oesophageal reconstruction with free jejunal flapFrancesco Perrone, Agnese Nitto, Yueh-bih Tang, et al.
Pageof 28

Showing results (51-60 of 272) with videos related to

Sort By:
Pageof 28
The Oncologist|August 2, 2006
Tyrosine kinase inhibitors of vascular endothelial growth factor receptors in clinical trials: current status and future directionsAlessandro Morabito, Ermelinda De Maio, Massimo Di Maio, et al.
Clinical Lung Cancer|July 25, 2008
An international, multicenter, randomized phase III study of first-line erlotinib followed by second-line cisplatin/gemcitabine versus first-line cisplatin/gemcitabine followed by second-line erlotinib in advanced non-small-cell lung cancer: treatment rationale and protocol dynamics of the TORCH trialCesare Gridelli, Charles Butts, Fortunato Ciardiello, et al.
Journal of Clinical Gastroenterology|October 24, 2002
Hepatocellular carcinoma: systemic treatmentsMassimo Di Maio, Ermelinda De Maio, Francesco Perrone, et al.
JAMA Network Open|December 2, 2022
Number Needed to Treat in Trials of Targeted Therapies for Advanced Ovarian CancerMichele Bartoletti, Sandro Pignata, Domenica Lorusso, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 19, 2009
Trastuzumab beyond progression: is the risk of cardiac toxicity really not increased?Alessandro Morabito, Maria Carmela Piccirillo, Ermelinda De Maio, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|February 28, 2012
The use of a chimaeric sero-muscular flap to prevent anastomotic leakage in head and neck reconstruction with free ileocolon flapFrancesco Perrone, Bahar Bassiri Gharb, Antonio Rampazzo, et al.
Tumori|April 20, 2026
Ethics in the evaluation of the quality of scientific research: An AIOM-TJ roundtableAlessio Vittorio Adani, Paolo Crosetto, Laura Galbiati, et al.
Journal of Cancer Policy|August 26, 2023
Cross-cultural adaptation of the PROFFIT Instrument to measure financial toxicity in people living with cancer within a UK populationAlkesh Patel, Francesco Perrone, Darren M Ashcroft, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2013
Reply to V. Lorusso et alCesare Gridelli, Ciro Gallo, Charles A Butts, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|November 1, 2012
Three uses of an extra length of jejunum in pharyngo-oesophageal reconstruction with free jejunal flapFrancesco Perrone, Agnese Nitto, Yueh-bih Tang, et al.
Pageof 28